ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

PRXL Parexel International Corp.

88.08
0.00 (0.00%)
02 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Parexel International Corp. NASDAQ:PRXL NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 88.08 88.10 88.11 0 01:00:00

PAREXEL International to Present at Goldman Sachs Global Healthcare Conference and Jefferies Healthcare Conference

24/05/2016 2:00pm

Business Wire


Parexel (NASDAQ:PRXL)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Parexel Charts.

PAREXEL International Corporation (NASDAQ: PRXL) announced today that executives will be making a presentation on PAREXEL and discussing business developments and financial outlook at two investor conferences in June.

  • Ingo Bank, Senior Vice President and Chief Financial Officer, will present at the Goldman Sachs Global Healthcare Conference in Rancho Palos Verdes, CA, on Tuesday, June 7, 2016 at 4:00 p.m. PDT.
  • Josef von Rickenbach, Chairman and Chief Executive Officer, will present at the Jefferies Healthcare Conference in New York City on Wednesday, June 8, 2016, at 1:30 p.m. EDT.

A live webcast of the presentation will be available through the “Investors” section of PAREXEL’s website at www.PAREXEL.com in the Upcoming Events portion of the main page, and a replay of the presentation will be available on the website for 90 days after the presentation.

About PAREXEL International

PAREXEL International Corporation is a leading global biopharmaceutical services company, providing a broad range of expertise-based clinical research, consulting, medical communications, and technology solutions and services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, and reimbursement. PAREXEL Informatics provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL has offices in 82 locations in 51 countries around the world, and had approximately 18,450 employees in the third quarter. For more information about PAREXEL International, visit www.PAREXEL.com.

PAREXEL InternationalRonald Aldridge, + 1-781-434-4753Senior Director of Investor RelationsRon.Aldridge@PAREXEL.com

1 Year Parexel Chart

1 Year Parexel Chart

1 Month Parexel Chart

1 Month Parexel Chart

Your Recent History

Delayed Upgrade Clock